The recent announcement from the Trump administration about significant funding cuts in biomedical research, specifically targeting the National Institutes of Health (NIH), has sent ripples of concern throughout the scientific community. This policy is set to immediately reduce "indirect" research
Artificial Intelligence (AI) is rapidly gaining momentum in the pharmaceutical industry, with healthcare professionals (HCPs) expressing enthusiastic optimism about its potential to revolutionize various aspects of healthcare, from drug discovery and diagnostics to patient care. This enthusiasm is
The gender data gap in medical research has significant implications for women's health, as it results in a systemic lack of data specifically addressing the unique experiences and health needs of women and girls. Women are frequently underrepresented in medical studies, and data often lacks gender
The NHS is currently experiencing immense pressure, manifested by record A&E wait times and the rising number of patients receiving treatment in temporary care environments, such as hospital corridors. These conditions reflect a grim reality: a health system overwhelmed by demand. Primary care
The COVID-19 pandemic has had far-reaching effects on various aspects of health, including pelvic health. As the public health emergency (PHE) comes to an end, it is essential to understand how this transition might impact individuals dealing with pelvic floor dysfunction (PFD) and related
Achieving trustworthiness and successful deployment of artificial intelligence (AI) in healthcare involves navigating a complex landscape of technology, ethics, and regulatory compliance. Given the critical nature of healthcare, it is imperative that AI systems are robust, fair, and transparent.
